Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-05-22 00:00:00 ET · period of report 2024-05-20 · accession 0001048477-24-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-22 | 2024-05-20 | BMRN | Hubbard Cristin | EVP, Chief Commercial Off | A - Grant | $0.00 | +19.4K | 14.7K | New | $0 |
| D | 2024-05-22 | 2024-05-20 | BMRN | Hubbard Cristin | EVP, Chief Commercial Off | A - Grant | $0.00 | +33.5K | 33.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-20 | A | A | 4,700 | $0.00 | 19,390 | D | — | — | (F1) Restricted stock units granted on May 20, 2024. Price not applicable. |
| 2 | Common | Common Stock | 2024-05-20 | A | A | 14,690 | $0.00 | 14,690 | D | — | — | (F1) Restricted stock units granted on May 20, 2024. Price not applicable. |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-05-20 | A | A | 33,520 | $0.00 | 33,520 | D | $77.05 · 2025-05-20 to 2034-05-19 | 33,520 Common Stock | (F2) Option grant vests 12/48th on May 20, 2025 and 1/48th on the 1st day of each month thereafter. |